Collins, Dorgan Introduce Bill To Reauthorize Critical Diabetes Research Funding

Posted In: Life Sciences

By The Associated Press

Wednesday, March 3, 2010

newsvine diigo google
slashdot
Share
Loading...

xfdpr COLLINS-RESEARCH-FUNDING sked

PRESS RELEASE

March 02, 2010

SUSAN COLLINS

SENATOR

SENATE

COLLINS, DORGAN INTRODUCE BILL TO REAUTHORIZE CRITICAL

DIABETES RESEARCH FUNDING

Roll Call, Inc.

1255 22nd Street N.W.

Washington, D.C. 20037

Transcript/Programming: Tel. 301-731-1728

Sales: Tel. 202-419-8500 ext 599

sales@cqrollcall.com

www.cqrollcall.com

Roll Call, Inc.

is a private firm not affiliated with the U.S. Government.

Copyright 2010 by Roll Call, Inc.

Washington, D.C. U.S.A. All materials herein are protected by United States copyright law

and may not be reproduced, distributed, transmitted, displayed,

published or broadcast without the prior written permission of

Roll Call, Inc. You may not alter or remove any trademark,

copyright or other notice from copies of the content.For Immediate Release

Collins, Dorgan Introduce Bill To Reauthorize Critical Diabetes Research Funding

Contact: Justin Kitsch, Dorgan, (202) 224-2551

March 3, 2010

WASHINGTON U.S. Senators Susan Collins (R-Maine) and Byron Dorgan (D-ND) have introduced bipartisan legislation to reauthorize the Special Diabetes Program, a critical public health program that improves diabetes research, treatment and prevention.

Since its inception in 1997, the Special Diabetes Program has funded significant Type 1 diabetes research as well as treatment initiatives targeted to American Indian and Alaska Native populations. The Dorgan-Collins reauthorization bill would provide each of these programs $200 million per year over the next five years.

"Reauthorization of these vital diabetes research programs will help millions of Americans who are suffering from diabetes, particularly in the Native American community, which is dramatically more affected by the disease than other ethnic groups," Dorgan said. "In addition, given that one of every five health care dollars is spent on treating individuals with diabetes, this program is a smart investment."

"Since I founded the Senate Diabetes Caucus, funding for diabetes research at the National Institutes of Health has more than tripled. After more than a decade of investment, the Special Diabetes Program is making tangible improvements in the lives of Americans who are living with diabetes. It is also making significant progress toward a cure.

Private organizations like the Juvenile Diabetes Research Foundation and the American Diabetes Association are also doing their part to fund research, support patients and families, and spur the government on to do even more. As a consequence, we have seen some encouraging breakthroughs and the development of better treatments.

We are on the threshold of a number of important new discoveries that may ultimately lead to cure. That is why it is critical that Congress extend funding for the Special Diabetes Program," Collins said. Currently, the Special Diabetes Program for Indians provides $150 million annually for Indian Health Services (IHS), tribes and tribal organizations, and urban Indian organizations to prevent and treat diabetes.

The Special Funding Program for Type 1 Diabetes allocates $150 million each year for research, development of therapies, and treatment methods to help diabetics treat the disease in the long term.

JOIN THE DISCUSSION
Rate Article:  Average 0 out of 5
Register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

New To Market

more

AFM and spectroscopy combined for physical and life sciences
AFM and spectroscopy combined for physical and life sciences

Veeco Instruments Inc. has designed its new IRIS models for Innova and BioScope Catalyst atomic force microscopes (AFMs) to provide superior integration and accessibility for combined AFM and Raman spectroscopy research.

Lenses optimized for peak SWIR performance

Enhanced 25-mm and 50-mm lenses from Navitar Inc. are specifically designed for short-wavelength infrared (SWIR) cameras. The lenses function in the wavelengths of 500 nm to 1700 nm, with 90% +/- 5% transmission across the range.

Tools & Technology

more

Syringe pump to deliver full stroke
Syringe pump to deliver full stroke

The Legato 270 Syringe Pump has an optimized user configurable syringe mechanism designed to deliver a full volume in infuse and withdraw modes whether using small or large syringes.

Potentiometric titrator can run four stations in parallel(2)

JM Science’s new Potentiometric Titrator (COM-1700) allows up to four different titrations to run in parallel at the same time.

Advertisement

Advertisement